We are participating in multiple clinical trials that use immunotherapy to deliver targeted treatment for endometrial cancer and teaming up with Mount Sinai immunologists to research potential vaccines. And we are exploring artificial intelligence tools to support decisions in fertility treatments.
In a particularly complex case, a mother with a severe congenital heart disorder delivered a healthy baby girl in the Cardiac Care Unit—thanks to a collaboration between our obstetrics team and cardiology.
An initiative is advancing both health equity and the patient experience, with tools including a dashboard with metrics to inform our clinical care; and the director of a new Division of Genetics and Genomics is leading an effort to make this state-of-the-art technology more accessible to all of the women we treat. Finally, two of our physician-scientists are the principal investigators of the first large-scale study of the effects of COVID-19 during and after pregnancy.
I hope that you and your families are well and safe, and that this material helps you in your own practice and research, and in the struggle with the historic COVID-19 pandemic and its aftereffects.
Michael Brodman, MD
Ellen and Howard C. Katz Chairman's Chair of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai